CJEU Advocate General: 25 member states can agree a unitary patent deal

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

CJEU Advocate General: 25 member states can agree a unitary patent deal

An important hurdle in the path of the unitary patent looks set to be dismantled after a key legal adviser at the Court of Justice of the EU said today that 25 member states should be able to press ahead with a deal without Italy and Spain

Last year the two countries asked Europe’s highest court to stop the European Council from pursuing the unitary patent package under the enhanced cooperation procedure.

The two countries are particularly unhappy about the proposal to make English, French and German the official languages of the unitary patent system.

Today Advocate General Bot said that the question of the language arrangements for the unitary patent “is not a condition that determines the validity of the decision authorising enhanced cooperation” and advised the Court to rule that Italy and Spain’s request to prevent the use of the enhanced cooperation procedure is inadmissible.

Italy and Spain had argued that enhanced cooperation procedure authorised by the Council would undermine the internal market and economic, social and territorial cohesion; constitute a barrier to trade between member states; and distort competition between them.

But Bot dismissed their claims. “To my mind there is no evidence that it would do so: indeed, it would do precisely the opposite,” he wrote.

Although the Court is not obliged to follow the Advocate General’s advice, it does in the majority of cases.

The Court of Justice is expected to rule in the case next year.

Keep up to date with all the unitary patent developments by bookmarking Managing IP's dedicated unitary patent page.






more from across site and SHARED ros bottom lb

More from across our site

Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Women are entering the IP profession, but still too few are being trusted with the clients, cases, and credit that may open the path to leadership
In other news, Australia’s IP office has announced expanded search options, and an EPO report shed light on slow progress relating to women inventors in Europe
Managing IP speaks with up-and-coming women lawyers at five law firms about fighting imposter syndrome, maintaining work-life balance and why real representation matters
Gift this article